BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36948970)

  • 1. A preoperative model for predicting early recurrence in patients undergoing resection for single hepatocellular carcinoma.
    Liu YW; Moi SH; Li WF; Lin CC; Yong CC; Wang CC; Yen YH; Lin CY
    Eur J Surg Oncol; 2023 Aug; 49(8):1444-1449. PubMed ID: 36948970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 5. Validation of an alpha-fetoprotein model to predict recurrence after liver resection for hepatocellular carcinoma.
    Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH
    Updates Surg; 2022 Aug; 74(4):1345-1352. PubMed ID: 34374920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative predictors of early recurrence after resection for hepatocellular carcinoma.
    Li WF; Yen YH; Liu YW; Wang CC; Yong CC; Lin CC; Cheng YF; Wang JH; Lu SN
    Am J Surg; 2022 May; 223(5):945-950. PubMed ID: 34399978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver resection for single large hepatocellular carcinoma: a prognostic factors study.
    Nguyen-Khac V; Brustia R; Rhaiem R; Regnault H; Sessa A; Mule S; Duvoux C; Laurent A; Leroy V; Calderaro J; Luciani A; Roudot-Thoraval F; Amaddeo G; Sommacale D
    Ann Hepatol; 2022; 27(6):100739. PubMed ID: 35781089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the hazard function to evaluate hepatocellular carcinoma recurrence risk after curative resection.
    Li WF; Moi SH; Liu YW; Yong CC; Wang CC; Yen YH; Lin CY
    Updates Surg; 2023 Dec; 75(8):2147-2155. PubMed ID: 37903995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
    Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
    Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
    Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
    J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the chance of cure after resection for hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guidelines: A multi-institutional analysis of 1,010 patients.
    Tsilimigras DI; Bagante F; Moris D; Merath K; Paredes AZ; Sahara K; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    Surgery; 2019 Dec; 166(6):967-974. PubMed ID: 31606196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis.
    Risaliti M; Bartolini I; Campani C; Arena U; Xodo C; Adotti V; Rosi M; Taddei A; Muiesan P; Amedei A; Batignani G; Marra F
    World J Gastroenterol; 2022 Aug; 28(29):3981-3993. PubMed ID: 36157535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver Imaging-Reporting and Data System treatment response algorithm predicts postsurgical recurrence in locoregional therapy-treated hepatocellular carcinoma.
    Youn SY; Kim B; Kim DH; Choi HJ; Sung PS; Choi JI
    Eur Radiol; 2022 Sep; 32(9):6270-6280. PubMed ID: 35348864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
    Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
    Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma.
    Lima HA; Moazzam Z; Endo Y; Alaimo L; Shaikh C; Munir MM; Resende V; Guglielmi A; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Endo I; Kitago M; Shen F; Pawlik TM
    Ann Surg Oncol; 2023 Jun; 30(6):3363-3373. PubMed ID: 36820934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative Predictors of Early Recurrence After Liver Resection for Multifocal Hepatocellular Carcinoma.
    Guo Y; Linn YL; Koh YX; Tan EK; Teo JY; Cheow PC; Jeyaraj PR; Chow PKH; Ooi LLPJ; Chung AYF; Chan CY; Goh BKP
    J Gastrointest Surg; 2023 Jun; 27(6):1106-1112. PubMed ID: 36857014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Preoperative Hypercoagulability with Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Liver Resection: A Multicenter Study.
    Zhang XP; Zhou TF; Wang ZH; Zhang F; Zhong CQ; Hu YR; Wang K; Chai ZT; Chen ZH; Wu MC; Lau WY; Cheng SQ
    Ann Surg Oncol; 2019 Nov; 26(12):4117-4125. PubMed ID: 31321582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.